Upgrade to SI Premium - Free Trial

Uncompensated Care Negatively Hits HCA Holdings (HCA) 3Q Results

October 28, 2015 10:14 AM
Leerink Partners maintained an Outperform rating on HCA Holdings (NYSE: HCA), and cut the price target to $79.00 (from $95.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles